Back
Ardelyx Vs. Verve Therapeutics Industry Stock Comparison
Sell
43
ARDX
Ardelyx
Last Price:
5.89
Seasonality Move:
32.33%
Sell
1
VERV
Verve Therapeutics
Last Price:
6.04
Seasonality Move:
-35.34%
Sell
43
Ardelyx (ARDX)
is a Sell
Is Ardelyx a Buy, Sell or Hold?
- The current Ardelyx [ARDX] share price is $5.89. The Score for ARDX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- ARDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Verve Therapeutics (VERV)
is a Sell
Is Verve Therapeutics a Buy, Sell or Hold?
- The current Verve Therapeutics [VERV] share price is $6.04. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ARDX Stock Price Chart
VERV Stock Price Chart
What is Verve Therapeutics's stock price today?
-
The Verve Therapeutics share price today is $6.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VERV is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 47.43 | Sell |
| Chaikin Money Flow: | -420545 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.7 - 6.48) | Sell |
| Bollinger Bands (100): | (5.58 - 6.4) | Sell |
VERV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 62.69 | Buy |
| Chaikin Money Flow: | 412752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
ARDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.91 | Sell |
| 20-day SMA: | 5.91 | Sell |
| 50-day SMA: | 6.07 | Sell |
| 200-day SMA: | 6.97 | Sell |
| 8-day EMA: | 5.92 | Sell |
| 20-day EMA: | 5.97 | Sell |
| 50-day EMA: | 6.04 | Sell |
| 200-day EMA: | 6.2 | Sell |
VERV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.89 | Buy |
| 20-day SMA: | 5.45 | Buy |
| 50-day SMA: | 5.41 | Buy |
| 200-day SMA: | 7.73 | Sell |
| 8-day EMA: | 5.85 | Buy |
| 20-day EMA: | 5.6 | Buy |
| 50-day EMA: | 5.51 | Buy |
| 200-day EMA: | 7.68 | Sell |
Ardelyx Earnings Growth & ARDX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.02 per share.
Verve Therapeutics Earnings Growth & VERV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.
Ardelyx Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Verve Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||